Protective immunity against heterologous challenge with encephalomyocarditis virus by VP1 DNA vaccination: effect of coinjection with a granulocyte-macrophage colony stimulating factor gene

By Sin J.-I.   Sung J.-H.   Suh Y.-S.   Lee A.-H.   Chung J.-H.   Sung Y.-C.  

Vaccine, Vol. 15, Iss. 17, 1997-12 ,pp. : 1827-1833

Elsevier

Access to resources Recommend Favorite

Prevention of neonatal tolerance by a plasmid encoding granulocyte-macrophage colony stimulating factor

By Ishii K.J.   Weiss W.R.   Klinman D.M.  

Vaccine, Vol. 18, Iss. 7, 1999-11 ,pp. : 703-710

Elsevier

Access to resources Recommend Favorite

Immune responses to an inactive vaccine against American cutaneous leishmaniasis together with granulocyte-macrophage colony-stimulating factor

By Follador I.   Araujo C.   Orge G.   Cheng L.H.   de Carvalho L.P.   Bacellar O.   Almeida R.P.   Carvalho E.M.  

Vaccine, Vol. 20, Iss. 9, 2002-01 ,pp. : 1365-1368

Elsevier

Access to resources Recommend Favorite

Enhanced cellular immunity to hepatitis C virus nonstructural proteins by codelivery of granulocyte macrophage-colony stimulating factor gene in intramuscular DNA immunization

By Cho J.H.   Lee S.W.   Sung Y.C.  

Vaccine, Vol. 17, Iss. 9, 1999-03 ,pp. : 1136-1144

Elsevier

Access to resources Recommend Favorite

Evaluation of tolerability and antibody response after recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and a single dose of recombinant hepatitis B vaccine

By Tarr P.E.   Lin R.   Mueller E.A.   Kovarik J.M.   Guillaumes M.   Jones T.C.  

Vaccine, Vol. 14, Iss. 13, 1996-09 ,pp. : 1199-1204

Elsevier

Access to resources Recommend Favorite